Suppr超能文献

评估作为M型钾电流调节剂的小分子候选物:对电流幅度、门控和电压依赖性滞后的影响。

Evaluation of Small-Molecule Candidates as Modulators of M-Type K Currents: Impacts on Current Amplitude, Gating, and Voltage-Dependent Hysteresis.

作者信息

Lu Te-Ling, Liutkevičienė Rasa, Rovite Vita, Gao Zi-Han, Wu Sheng-Nan

机构信息

Department of Pharmacy, China Medical University, Taichung 406040, Taiwan.

Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 2, 50161 Kaunas, Lithuania.

出版信息

Int J Mol Sci. 2025 Feb 11;26(4):1504. doi: 10.3390/ijms26041504.

Abstract

The core subunits of the K7.2, K7.3, and K7.5 channels, encoded by the , , and genes, are expressed across various cell types and play a key role in generating the M-type K current (). This current is characterized by an activation threshold at low voltages and displays slow activation and deactivation kinetics. Variations in the amplitude and gating kinetics of can significantly influence membrane excitability. Notably, demonstrates distinct voltage-dependent hysteresis when subjected to prolonged isosceles-triangular ramp pulses. In this review, we explore various small-molecule modulators that can either inhibit or enhance the amplitude of , along with their perturbations on its gating kinetics and voltage-dependent hysteresis. The inhibitors of highlighted here include bisoprolol, brivaracetam, cannabidiol, nalbuphine, phenobarbital, and remdesivir. Conversely, compounds such as flupirtine, kynurenic acid, naringenin, QO-58, and solifenacin have been shown to enhance . These modulators show potential as pharmacological or therapeutic strategies for treating certain disorders linked to gain-of-function or loss-of-function mutations in M-type K (K7x or ) channels.

摘要

由 、 和 基因编码的K7.2、K7.3和K7.5通道的核心亚基在多种细胞类型中表达,并在产生M型钾电流( )中起关键作用。该电流的特征是在低电压下有一个激活阈值,并表现出缓慢的激活和失活动力学。 的幅度和门控动力学变化可显著影响膜兴奋性。值得注意的是,当受到延长的等腰三角形斜坡脉冲作用时, 表现出明显的电压依赖性滞后现象。在本综述中,我们探讨了各种可抑制或增强 幅度的小分子调节剂,以及它们对其门控动力学和电压依赖性滞后的扰动。这里重点介绍的 的抑制剂包括比索洛尔、布立伏西坦、大麻二酚、纳布啡、苯巴比妥和瑞德西韦。相反,氟吡汀、犬尿氨酸、柚皮素、QO-58和索利那新等化合物已被证明可增强 。这些调节剂显示出作为治疗与M型钾(K7x或 )通道功能获得或功能丧失突变相关的某些疾病的药理学或治疗策略的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9824/11855363/fcf8c56d9a0a/ijms-26-01504-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验